Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell Therapeutics
Pharma
Bristol Myers bags FDA nod to bring CAR-T to CLL
BMS' Breyanzi, a one-time CAR-T therapy, will compete with Eli Lilly's Jaypirca, a chronic oral drug, in CLL following BTK and BCL-2 inhibitors.
Angus Liu
Mar 15, 2024 9:46am
Legend CEO offers preview of high-stakes FDA adcomm for Carvykti
Mar 11, 2024 1:29pm
FDA approves first T-cell therapy for a solid tumor
Feb 17, 2024 12:15pm
FDA sets date for high-profile CAR-T advisory committee meeting
Feb 2, 2024 1:31pm
ASH: Abecma's overall survival data show why FDA called adcomm
Dec 11, 2023 7:30pm
ASH: Study digs into FDA adverse event record of BCMA therapies
Dec 11, 2023 2:46am